Tandem Diabetes Care has been granted a patent for portable infusion devices and systems that can remotely update ambulatory fluid delivery devices. The patent includes safety protocols to verify the device’s status before and after a software update. The method involves determining the availability of a software update, confirming a wireless connection, ensuring a safe condition for the update, transmitting the update wirelessly, and obtaining user confirmation before installing the update. GlobalData’s report on Tandem Diabetes Care gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Tandem Diabetes Care Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Tandem Diabetes Care, Wearable drug delivery devices was a key innovation area identified from patents. Tandem Diabetes Care's grant share as of September 2023 was 48%. Grant share is based on the ratio of number of grants to total number of patents.

Remote software update for ambulatory infusion pump control device

Source: United States Patent and Trademark Office (USPTO). Credit: Tandem Diabetes Care Inc

A recently granted patent (Publication Number: US11776689B2) describes a method for remotely updating software on a remote control device used to control the operations of an ambulatory infusion pump. The method involves several steps to ensure the safe and successful installation of the software update.

The first step is to determine whether a software update is available for the remote control device. Once confirmed, an active wireless connection with the remote control device is established. The method then verifies that a safe condition exists for the software update, which includes checking if the infusion pump is not currently administering medication, not attached to a patient, and the medicament reservoir is not in fluid communication with the patient.

If a safe condition is confirmed, the software update is automatically wirelessly transmitted to the remote control device. The method also includes verifying that the user wishes to proceed with the software update before enabling the installation of the update on the remote control device.

Additional steps in the method involve verifying the safe condition for the operation of the ambulatory infusion pump after the software update. This includes checking the pump's ability to dispense medication, update a device history log, and accept sensor data for medicament dosing. The method also includes receiving information to verify the absence of error messages related to the pump's operation.

Compatibility of the remote control device with the software update is also verified, including checking the memory capacity and device model compatibility. Furthermore, information is received to verify that the pump performs as intended after the software update.

The method also ensures that the battery of the remote control device has a sufficient level of charge before installing the software update.

Overall, this patent describes a comprehensive method for remotely updating software on a remote control device used for an ambulatory infusion pump. By verifying safe conditions, user consent, and compatibility, the method aims to ensure the successful and safe installation of software updates, enhancing the functionality and performance of the ambulatory infusion pump system.

To know more about GlobalData’s detailed insights on Tandem Diabetes Care, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.